Skip to main content

COVID19

  • COVID-19

COVAX

  • COVAX

Country Hub

  • Country Portal

Secondary nav

  • Global Vaccine Summit
  • Ethics Hotline

Donate

  • Donate
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Vaccine investment strategy
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil society organisations
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • The Vaccine Innovation Prioritisation Strategy
      • Supply and procurement roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    @SaveTheChildren / Hanna Adcock

    #VaccinesWork  

    Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

    FOCUS AREAS Gavi@20 Progress report Partners Our Board


    CAREERS Current vacancies Internship programme RFPs and consulting


    Contact us Phishing and fraud

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Support guidelines
        • Apply for vaccine support
        • Apply for health system strengthening support
        • Apply for cold chain equipment support
        • Report on and renew existing Gavi support
        • Access targeted country assistance
        • Additional support guidance documentation
      • Independent Review Committee
      • Joint appraisals
      • Grant performance frameworks
      • Country portal
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Transitioning out of Gavi support
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Cuba
        • Haiti
        • Honduras
        • Nicaragua
        • Bolivia
        • Guyana
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • Southeast Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011 - 2015 indicators
        • 2016 - 2020 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
        • Accelerated Vaccine Introduction project review
        • ADIPs and Hib Initiative Evaluation
        • Baseline study for AMC
        • Co-financing, eligibility and transition policies evaluation 2019
        • Cold Chain Equipment Optimization Platform Evaluation
        • Co-financing Policy Evaluation
        • Evaluation of Gavi support to CSO 2012
        • Evaluation of Gavi support to CSO 2018
        • Evaluation of the drivers of urban immunisation in Uganda; Kampala case study (Phase 1)
        • Full country evaluations
        • Gavi first evaluation report
        • Gavi second evaluation report
        • Gavi support to Albania evaluation
        • Gavi support to Bosnia and Herzegovina evaluation
        • Gavi-Government of China Hepatitis B vaccination programme
        • Gender policy evaluation
        • Gender policy evaluation 2019
        • Health system strengthening evaluations
        • IFFIm evaluation
        • Immunisation services support evaluation
        • Injection safety support evaluation
        • Measles campaigns in Nigeria
        • Mid-Term Evaluation of MoU8
        • Pneumococcal AMC outcomes and impact evaluation
        • Pneumococcal AMC process and design
        • Review of IRCs
        • Technical assistance through the Partners Engagement Framework evaluation
        • Using Geospatial Technologies to improve immunisation coverage and equity
        • Other studies
        • Using digital technologies for real-time supplementary monitoring of immunisation activity
      • Facts and figures
      • Progress reports
    • Programmatic Policies
      • Co-financing policy
      • Eligibility and transitioning
      • Fragility, emergencies and refugees policy
      • Gender policy
      • Health system and immunisation strengthening support framework
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesGavi supported a total of 73 countries in 2018
    Explore our Country Hub ->

    FOR COUNTRIES

    Apply for support

    Renew support

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Resource mobilisation process
      • Global Vaccine Summit 2020
      • Gavi's Investment Opportunity launch meeting, 30 August 2019
      • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
      • Gavi pledging conference January 2015
      • Gavi replenishment launch meeting May 2014
      • Gavi Mid-Term Review meeting October 2013
      • Gavi pledging conference June 2011
      • Call for Action and Resources October 2010
      • Financing Country Demand March 2010
    • Funding
      • Overview 2000-2037
      • Current period 2016-2020
      • Donor profiles
        • Airtel Nigeria
        • Al Ansari Exchange
        • Alwaleed Philanthropies
        • Audacious Alliance
        • Australia
        • The Bill & Melinda Gates Foundation
        • Brazil
        • Burkina Faso
        • Cameroon
        • Canada
        • The Children’s Investment Fund Foundation (UK)
        • China
        • China Merchants Charitable Foundation
        • Colombia
        • Comic Relief
        • Denmark
        • ELMA Vaccines and Immunization Foundation
        • European Commission
        • Finland
        • France
        • Germany
        • Girl Effect
        • Greece
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Kingdom of Bhutan
        • Kingdom of Saudi Arabia
        • KS Relief
        • "la Caixa" Banking Foundation
        • Laerdal
        • Lions Club International Foundation (LCIF)
        • LDS Charities
        • Luxembourg
        • Mastercard
        • Mauritius
        • The Netherlands
        • New Zealand
        • Niger
        • Norway
        • Orange
        • Other private donors
        • Portugal
        • Principality of Monaco
        • Reckitt Benckiser Group
        • Red Nose Day Fund
        • Reed Hastings and Patty Quillin
        • Republic of Korea
        • Rockefeller Foundation
        • Russian Federation
        • South Africa
        • Spain
        • State of Qatar
        • State of Kuwait
        • Sultanate of Oman
        • Sweden
        • Switzerland
        • TikTok
        • TransferWise
        • Uganda
        • Unilever
        • United Kingdom
        • United States of America
        • UPS
    • Partnering with business
      • Financial partnerships
      • Leveraged partnerships
      • Operational partnerships
      • Become a partner
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • About the pneumococcal AMC
        • How it works
        • Manufacturers
        • How countries can apply
        • Timeline
        • Independent Assessment Committee
        • AMC legal agreements
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    GLOBAL VACCINE SUMMIT

    World leaders make historic commitments to provide equal access to vaccines for all

    KEY AREAS

    Donor profiles

    Matching Fund

    Pneumococcal AMC

  • #VaccinesWork
    #VaccinesWork
    • COVID-19
    • Country stories
    • Photo stories
    • Videos
    • Opinions
    • Value of vaccination
      • Added value
      • Cost-effective
      • Health equity
      • Tried and tested

    FEATURED STORY

    International Women's Day 2021

     

  • News & Resources
    News & Resources
    • Media room
      • News releases
      • Media contacts
      • Leadership biographies
    • Audio-visual
      • Videos
      • Galleries
      • Infographics
      • Presentations
    • Publications
    • Document library
      • COVID-19 situation reports
      • Evaluations
      • IRC reports
      • Financial reports

    KEY PUBLICATION

    Gavi innovation catalogue

     

    PROGRESS REPORT

    Download the 2019 Gavi progress report

  • EN
  • FR
  • Home
  • News and resources
  • Audio visual
  • Infographics
Back to

Infographics

Visual representations of key information and data related to immunisation and the work of the Vaccine Alliance

Infographics

Visual representations of key information and data related to immunisation and the work of the Vaccine Alliance

 

February 7, 2018

Immunisation keeps millions out of poverty

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

November 12, 2016

Pneumococcal disease: the leading vaccine-preventable cause of death in children under five

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

March 21, 2016

Immunisation - a healthy return on investment

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

March 6, 2015

Protecting women from one of the biggest cancer killers in developing countries

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

February 4, 2015

Cost-effective vaccines to prevent cancer

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

December 10, 2014

Immunisation: No other health intervention touches so many lives

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

November 12, 2014

Pneumococcal disease: the biggest vaccine-preventable cause of death in children under five

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

November 4, 2014

Nearly one third of all unimmunised children live in India

Gavi, the Vaccine Alliance"
      },
       "publisher": {
        "@type": "Organization
Learn more

November 3, 2014

2 in 5 children are immunised with Gavi support

Gavi, the Vaccine Alliance"      },       "publisher": {        "@type": "Organization
Learn more
Last updated: 11 Dec 2019

Subscribe to our newsletter

Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • #VaccinesWork
  • News & resources

Country Hub

  • Country Portal

Donate

  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy Policy
  • Terms of use
  • Phishing and fraud

© Gavi 2020

  • Gavi Facebook
  • Gavi Twitter
  • Gavi LinkedIn

Our achievements are thanks to the support and expertise of our founding partners